Le Lézard
Classified in: Health
Subject: WOM

US Drug Watchdog Urges Women Nationwide to Demand Their Physician Explain the Risks of Using a Mesh Product to Treat Urinary Incontinence or Pelvic Organ Prolapse Before It is Used in a Surgical Procedure-Malpractice Should Be on the Table


WASHINGTON, Nov. 16, 2022 /PRNewswire/ -- The US Drug Watchdog says, "Over a decade ago we were one of the most quoted sources in the nation for victims of transvaginal mesh failures and we helped hundreds of women who were harmed by these types of medical products. We moved on from this initiative until a few months ago when we received a call from a young woman on the West Coast who had medical procedure using a mesh product to treat urinary incontinence very early in 2022."

"Since her vaginal mesh surgical procedure, she has had to go through four revision surgeries in an attempt to remove this product from her body. The doctor who performed the procedure and the hospital are not returning her calls. Why are mesh products still being used-and or why haven't the mesh product makers fixed the very serious issues with these types of medical products?"

"The medical doctor who used a vaginal mesh product on this young mother-never bothered to mention the serious issues with these types of surgical mesh products. These are extremely serious problems that have persisted for more than a decade with these types of medical products. How many women will have their lives destroyed because they underwent a surgical procedure using a mesh product in their vagina to treat urinary incontinence or pelvic organ prolapse?"

"If you are a woman about to undergo a medical procedure where a mesh product is going to be used to treat urinary incontinence or pelvic organ prolapse-please ask your doctor about the risks-and have a witness there." https://USDrugWatchdog.Com

When the US Drug Watchdog spoke with the young woman it occurred to the group this might be a case of medical malpractice-because the woman's doctor never mentioned very serious issues with mesh products in general, and more specifically mesh products designed to treat women who were suffering from urinary incontinence or pelvic organ prolapse. The Watchdog contacted a dozen law firms, and no one wanted this young woman's possible case----the law firms they contacted simply wanted to sign the woman up for a class action-aka-multi district litigation-MDL. 

Some symptoms of a vaginal mesh procedure-failure include:

According to the US Drug Watchdog, "If you are a partner at a law firm that does medical malpractice cases on a nationwide basis, and you might have the ability to assist women who have had a catastrophic mesh surgery in 2022-that was intended to treat urinary incontinence or pelvic prolapse-please give us a call at 866-714-6466. There are probably a lot of other women who need your services-nationwide." https://USDrugWatchdog.Com

Media Contact:
Michael Thomas
866-714-6466
[email protected] 

SOURCE US Drug Watchdog


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: